Wellington Management Group
GEVA

Wellington Management Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Wellington Management Group’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-593,823
Closed -$57.9M – 2312
2015
Q1 		$57.9M Buy
593,823
+456,236
+332% +$48.3M 0.01% 683
2014
Q4 		$12.8M Buy
137,587
+32,130
+30% +$2.54M ﹤0.01% 1168
2014
Q3 		$7.25M Sell
105,457
-1,582
-1% -$113K ﹤0.01% 1333
2014
Q2 		$11.2M Sell
107,039
-30
-0% -$2.55K ﹤0.01% 1225
2014
Q1 		$8.88M Sell
107,069
-14,349
-12% -$1.33M ﹤0.01% 1286
2013
Q4 		$7.86M Sell
121,418
-9,422
-7% -$559K ﹤0.01% 1318
2013
Q3 		$8.28M Sell
130,840
-25,400
-16% -$1.25M ﹤0.01% 1270
2013
Q2 		$6.56M Buy
+156,240
New +$7.12M ﹤0.01% 1342

Wellington Management Group's GEVA Position: Q2 2015 in Review

Wellington Management Group sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 593,823 shares — an estimated $57.9M sold.

Wellington Management Group first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $57.9M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Wellington Management Group reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Wellington Management Group sold 593,823 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $57.9M.
  • Wellington Management Group first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Wellington Management Group's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $57.9M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Wellington Management Group's 13F filing for Q2 2015, filed 14 Aug 2015.